BioSpace News Archive

Alphamab Oncology (stock code: 9966 HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to KN046, a recombinant humanized PD-L1/CTLA-4 bispecific antibody developed by Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (“Jiangsu Alphamab”), a wholly-owned subsidiary of the company, f

CannaGlobal Canada Co. Inc., Sansero Life Sciences Inc., and Rise Wellness this week announced the completion of their amalgamation to form CannaGlobal Wellness, a global psychedelics leader focused on psilocybin and other natural compounds to promote emotional, mental, and physical wellness. Sansero Life Sciences is developing psilocybin-based pharmaceutical products to treat mental health conditions, and Rise Wellness has

Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, President and Chief Executive Officer, and Brian Poff , Executive Vice President and Chief Financial Officer, will participate in the Baird 2020 Global Healthcare Conference, which is being held as a virtual event on

Technology applies “clean room” principles to create a safe, breathable environment for the nose and mouth while filtering exhaled breath

BEDFORD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer, and Michael Levitz, Chief Financial Officer, will participate in the following four virtual investor conferences in September: Barrington Research Fa

Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, Sept. 9. A webcast of the event will be available for the investment community. The details: What: Wells Fargo 2020 Virtual Healthcare Conference When: Wednesday, Sept. 9 at 10:40 a.m. (EDT) Who: Bob McMahon, Agilent chief financial officer Wh

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (AAV) based gene therapies for the treatment of rare inherited diseases, today announced that management will be participating in the following virtual conferences: 2020 Wells Fargo Virtual Healthcare Conference (September 9-10, 2020) Sue Washer, President & Chief Executive Officer, wi

Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market (the “ Minimum Bid Price Requirement ”). On September 2, 2020, Organovo received a letter from the Listing Qualifications Department of The Nasdaq Stock Market, Inc. stating that because Organovo’s common stock had a closing bid price at or a

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in the following upcoming investor conferences: The Morgan Stanley 18th Annual Global Healthcare Conference Management will participate in a firesi

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs ™ ), today announced that Sarah Boyce , Avidity’s President and CEO, will participate in a fireside chat at the 2020 Wells Fargo Virtual Healthcare Conference